25.12.2014 Views

Knyga 2008 09_2 be EndNote.indd - Saulius Čaplinskas

Knyga 2008 09_2 be EndNote.indd - Saulius Čaplinskas

Knyga 2008 09_2 be EndNote.indd - Saulius Čaplinskas

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Atsako į AIDS ir narkomaniją kontroversijos<br />

Literatūros sąrašas<br />

1 Čaplinskas S, Liutkevičienė I. AIDS: geriau žinoti. Vilnius: Tyto alba,<br />

20<strong>09</strong>: 150.<br />

2 Čaplinskas S. ŽIV/AIDS profilaktikos programų efektyvumas. Lietuvos<br />

<strong>be</strong>ndrosios praktikos gydytojas 2004; 8(3): 2<strong>09</strong>-14.<br />

3 Blower SM, McLean AR. Prophylactic vaccines, risk <strong>be</strong>havior change,<br />

and the probability of eradicating HIV in San Francisco. Science 1994;<br />

265(5177): 1451–54.<br />

4 Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis<br />

for HIV prevention in men who have sex with men. N Engl J Med 2011;<br />

363: 2587–99.<br />

5 Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness<br />

and safety of tenofovir gel, an antiretroviral microbicide, for the<br />

prevention of HIV infection in women. Science. 2010; 329 : 1168–74.<br />

6 Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, et al. Vaccination with<br />

ALVAC and AIDSVAX to prevent HIV -1 infection in Thailand. N Engl J<br />

Med 20<strong>09</strong>; 361: 22<strong>09</strong>–20.<br />

7 Likatavičius G, Čaplinskas S, Rakickienė J. HIV/AIDS epidemiology in<br />

Lithuania. Acta medica Lituanica. 2001; suppl.6: 17-24.<br />

8 Hamers FF, Downs AM. HIV in central and eastern Europe. Lancet<br />

2003; 361(9362):1035-44.<br />

9 Čaplinskienė I. Ar gali ŽIV infekcija iš didelės rizikos tikslinių grupių<br />

plisti į <strong>be</strong>ndrąją populiaciją Lietuvoje. Medinfo 2004; 3: 37-9.<br />

10 Čaplinskas S. Moksliškai pagrįsti priklausomumo nuo narkotikų gydymo<br />

modeliai. Nervų ir psichikos ligos: specializuotas „Gydymo meno”<br />

priedas. 2004; 1 (13): 35.<br />

11 Čaplinskas S. ŽIV plitimo tarp narkotikų vartotojų prevencijos principai.<br />

Gydymo menas. ISSN 1392-527X. 2003; 9: 24-5.<br />

12 Čaplinskas S. Narkotikų kontrolė: pragmatiška politika ir humanistinės<br />

nuostatos. Acta medica Lituanica. 2001; suppl.6: 37-41.<br />

13 Södergard B, Halvarsson M, Tully MP, et al. Adherence to treatment in<br />

Swedish HIV-infected patients. J Clin Pharm Ther 2006; 31(6):605-16.<br />

14 Hilton BA, Thompson R, Moore-Dempsey L, et al. Harm reduction<br />

theories and strategies for control of human immunodeficiency virus:<br />

a review of the literature. Journal of Advanced Nursing 2001; 33(3):<br />

357-70.<br />

15 Report on the global HIV/AIDS epidemic. Geneva: UNAIDS 2002.<br />

16 UNAIDS terminology guidelines, <strong>2008</strong>.<br />

17 Mazus AI, Leven II, Vinogradova OV, Zelenev VV, Makarenko OV. The<br />

sociological monitoring as a tool to evaluate preventive activities.<br />

Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med 20<strong>09</strong>; 3:32-4.<br />

18 Conference Summary Report on the 6th IAS Conference on HIV<br />

Pathogenesis, Treatment and Prevention (IAS 2011).17-20 July 2011.<br />

Rome, Italy.<br />

19 Nuo patirties perėmėjo iki geros praktikos skleidėjo – tai 20 metų AIDS<br />

centro veiklos bagažas: [pokalbis su Lietuvos AIDS centro direktoriumi<br />

Sauliumi Čaplinsku]. – Nuotr. // Lietuvos medicinos kronika. – 20<strong>09</strong>,<br />

liepos 1, p. 7, 8.<br />

20 25-eri metai su AIDS: [pokalbis su Lietuvos AIDS centro direktoriumi<br />

Sauliumi Čaplinsku]. – Nuotr. // Lietuvos medicinos kronika. – 20<strong>09</strong>,<br />

liepos 15, p. 5, 8.<br />

21 Caplinskiene I, Caplinskas S. Antiretroviral therapy (ART) coverage<br />

and expenditures for ART in Lithuania. Abstract book „HIV in European<br />

region – unity and diversity”, Tallinn, May 25-28, 2011; 168.<br />

22 Lee CK, Lee HK, Loh TP, et al. An in-house HIV genotyping assay for the<br />

detection of drug resistance mutations in Southeast Asian patients<br />

infected with HIV-1. J Med Virol 2012; 84(3):394-401.<br />

23 Kolupajeva T, Aldins P, Guseva L, Dusacka D, Sondore V, Viksna L,<br />

Rozentale B. HIV drug resistance tendencies in Latvia. Cent Eur J<br />

Public Health <strong>2008</strong>; 16(3):138-40.<br />

24 Rolleston Report. Departmental Commission on Morphine and<br />

Heroin Addiction, United Kingdom. 1926. Prieiga per internetą: http://<br />

www.drugtext.org/Table/Rolleston-Report/.<br />

25 Waal H. Risk reduction as a component of a comprehensive, multidisciplinary<br />

approach to drug abuse problems. Discussion paper.<br />

P-PG/MIN/CONF 2000; 3. Prieiga per internetą: https://wcd.coe.int/<br />

ViewDoc.jspid=1302287&Site=COE<br />

26 Satel SL. What should we expect from drug abusers Psychiatric<br />

Services. 1999;50(7):861.<br />

27 Califano JA. Should drugs <strong>be</strong> decriminalised No. BMJ 2007;<br />

335(7627):967.<br />

28 Collins L. Nepasisekęs Olandų eksperimentas su narkotikais. Vilnius<br />

1999; 8.<br />

29 First Conference, European Cities at the Centre of Illegal Trade in<br />

Drugs, Documentation, Frankfurt a/Main (Germany), 20-22.11.1990.<br />

30 ECAD Declaration for a Drug-free World. Prieiga per internetą:<br />

(http://www.drugnews.nu/article.aspid=4676)<br />

31 Nadelman EA, Cohen P, Drucker E, Locher U, Stimson G, Wodak A. The<br />

Harm Reduction Approach to Drug Control: International Progress.<br />

1994. Prieiga per internetą:http://www.paranoia.cin.drugs/war.<br />

on.drugs/debate/harm-reduction.html.<br />

32 Chand K. Should drugs <strong>be</strong> decriminalised Yes. BMJ 2007;<br />

335(7627):966.<br />

33 Lines R, Elliott R. Injecting drugs into human rights advocacy.<br />

International Journal of Drug Policy 2007;18:453–457.<br />

34 Hunt N. Public health or human rights: What comes first International<br />

Journal of Drug Policy 2004;15(4):231–237.<br />

35 Grossman M, Chaloupka FJ, Shim K. Illegal Drug Use And Public Policy.<br />

Health Affairs 2002; 21 (2):134-145.<br />

36 Smye V, Browne AJ, Varcoe C, Josewski V. Harm reduction, methadone<br />

maintenance treatment and the root causes of health and social<br />

inequities: An intersectional lens in the Canadian context. Harm<br />

Reduct J 2011;8(1):17.<br />

37 Van Amsterdam J, Opperhuizen A, Koeter M, van den Brink W. Ranking<br />

the harm of alcohol, tobacco and illicit drugs for the individual and<br />

the population. Eur Addict Res. 2010;16(4):202-7.<br />

38 Nutt D, King LA, Saulsbury W, Blakemore C. Development of a rational<br />

scale to assess the harm of drugs of potential misuse. Lancet 2007;<br />

369: 1047–1053.<br />

39 Anderson P, Chisholm D, Fuhr DC. Effectiveness and cost-effectiveness<br />

of policies and programmes to reduce the harm caused by alcohol.<br />

Lancet 20<strong>09</strong>;373(9682):2234-46.<br />

40 Anderson P, Baum<strong>be</strong>rg B. Alcohol in Europe. London: Institute of<br />

Alcohol Studies; 2006. Prieiga per internetą: http://ec.europa.eu/<br />

health-eu/news_alcoholineurope_en.htm<br />

41 Anderson P, Baum<strong>be</strong>rg B. Alcohol in Europe. London: Institute of<br />

Alcohol Studies. 2006. Prieiga per internetą: http://ec.europa.eu/<br />

health/archive/ph_determinants/life_style/alcohol/documents/<br />

alcohol_europe_en.pdf<br />

42 Waal H. Drug use policies and HIV prevention – unhappy <strong>be</strong>dfellows<br />

In: Waal H. (ed.): Patterns on the European drug scene. An exploratory<br />

of differences. Report based on a COST A6 project. National Institute<br />

for Alcohol and Drug Research, Oslo 1998; 211-8.<br />

43 EMCDDA 2011 m. metinė ataskaita: narkotikų problema Europoje.<br />

Europos Sąjungos leidinių biuras, Liuksemburgas, 2011; 107.<br />

44 EMCDDA. Illicit drug use in the EU: legislative approaches. European<br />

Monitoring Centre for Drugs and Drug Addiction, Lisbon 2005.<br />

45 Amundsen E J, Eskild A, Stigum H, Smith E, Aalen OO. Legal access<br />

to needles and syringes/ needle exchange programmes versus<br />

HIV counselling and testing to prevent transmission of HIV among<br />

intravenous drug users . A comparative study of Denmark, Norway<br />

and Sweden. Eur J Public Health 2003: 13(3): 252-258.<br />

46 Palm J. Moral concerns – Treatment staff and user perspec tives on<br />

63

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!